x
Volume 42 Issue 1
Apr.  2020
Turn off MathJax
Article Contents
Article Navigation >  Journal of Molecular Imaging  > 2020  >  43(1): 41-44
Zhongming WU, Yunbo LI, Weiqi WANG, Jianhua WEI. Application value of PET/MR in surgery of Oral and Maxillofacial malignant tumors[J]. Journal of Molecular Imaging, 2020, 43(1): 41-44. doi: 10.12122/j.issn.1674-4500.2020.01.09
Citation: Zhongming WU, Yunbo LI, Weiqi WANG, Jianhua WEI. Application value of PET/MR in surgery of Oral and Maxillofacial malignant tumors[J]. Journal of Molecular Imaging, 2020, 43(1): 41-44. doi: 10.12122/j.issn.1674-4500.2020.01.09
shu

Application value of PET/MR in surgery of Oral and Maxillofacial malignant tumors

doi: 10.12122/j.issn.1674-4500.2020.01.09
  • 1.

    State Key Laboratory of Military Stomatology / National Clinical Research Center for Oral Diseases / Shaanxi Clinical Research Center for Oral Diseases, Department of Oral and Maxillofacial Surgery, School of Stomatology, the Fourth Military Medical University, Xi`an 710032, China

  • 2.

    Department of Nuclear Medicine, Second Affiliated Hospital of Air Force Military Medical University, Xi`an 710038, China

  • Received Date: 2020-01-03
  • Publish Date: 2020-01-01
    Abstract
  • The incidence of oral and maxillofacial tumors was increased year by year. Surgery is still an important treatment at present. The surgical plan and postoperative prognosis depend on the size of cancer, the extent of invasion,whether accompanied by lymph node metastasis and distant metastasis. Imaging examination plays a more and more important role in the preoperative evaluation in patient with oral and maxillofacial tumors. PET/MR is the most advanced molecular imaging equipment in the world, the perfect combination of structure and functional imaging plays an indispensable role in the diagnosis and treatment of tumors, but its clinical application value in oral and maxillofacial tumors is rarely reported. The purpose of this review is to explore the application value of PET/MR in oral and maxillofacial tumors through clinical cases combined with relevant literature at home and abroad.

     

    • FullText(HTML)
  • loading
    • References(31)
  • [1]
    Afzali P, Ward BB. Management of the neck in oral squamous cell carcinoma[J]. Oral Maxillofac Surg Clin North Am, 2019, 31(3): 69-84.
    [2]
    Kitamoto E, Chikui T, Kawano S, et al. The application of dynamic contrast-enhanced MRI and diffusion-weighted MRI in patients with maxillofacial tumors[J]. Acad Radiol, 2015, 22(4): 210-6.
    [3]
    Asaumi J, Yanagi Y, Hisatomi M, et al. The value of dynamic contrastenhanced MRI in diagnosis of malignant lymphoma of the head and neck[J]. Eur J Radiol, 2003, 48(2): 183-7. doi: 10.1016/S0720-048X(02)00347-9
    [4]
    杜燕飞, 滕建波, 李传亭. 超声弹性成像在腮腺肿瘤诊断中的研究进展[J]. 医学影像学杂志, 2014, 24(5): 484-6.
    [5]
    De BR, Castelijns JA, Hokestra OS, et al. Advances in imaging in the work-up of head and neck cancer patients[J]. Oral Oncol, 2009, 45(10): 930-5.
    [6]
    Hisatomi M, Asaumi J, Yanagi Y, et al. Diagnostic value of dynamic contrast-enhanced MRI in the salivary gland tumors[J]. Oral Oncol, 2007, 43(12): 940-7.
    [7]
    Eida S, Sumi M, Nakamura T. Multiparametric magnetic resonance imaging for the differentiation between benign and malignant salivary gland tumors[J]. J Magn Reson Imaging, 2010, 31(8): 673-9.
    [8]
    Matsuzaki H, Yanagi Y, Hara M, et al. Minor salivary gland tumors in the oral cavity: diagnostic value of dynamic contrast-enhanced MRI[J]. Eur J Radiol, 2012, 81(13): 2684-91.
    [9]
    Lombardi D, Accorona R, Lambert A, et al. Long-term outcomes and prognosis in submandibular gland malignant tumors: a multicenter study[J]. Laryngoscope, 2018, 128(15): 2745-50.
    [10]
    Singh D, Sahoo S, Gupta V, et al. Latest advancements in imaging of oral and maxillofacial neoplasm: a comprehensive review[J]. J Oral Maxillofac Radiol, 2013, 20(1): 37-42.
    [11]
    Adelstein D, Gillison ML, Pfister DG, et al. NCCN guidelines insights: head and neck cancers, version 2[J]. J Natl Compr Cancer Netw, 2017, 15(9): 761-70.
    [12]
    Ng SH, Chan SC, Yen TC, et al. Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up[J]. Eur J Nucl Med Mol Imaging, 2009, 36(1): 12-22. doi: 10.1007/s00259-008-0918-7
    [13]
    Chan SC, Yeh CH, Yen TC, et al. Clinical utility of simultaneous whole-body 18F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma[J]. Europ J Nuclear Med Molecul Imaging, 2018, 45(10): 1297-308.
    [14]
    Roh JL, Yeo NK, Kim JS, et al. Utility of 18F-FDG PET/CT in the preoperative staging of head and neck squamous cell carcinoma[J]. Oral Oncol, 2007, 43(12): 887-93.
    [15]
    Ming HM, Shu W, Zhi-en F, et al. Accuracy of magnetic resonance imaging in evaluating the depth of invasion of tongue cancer: a prospective cohort study[J]. Oral Oncol, 2019, 91(2): 79-84.
    [16]
    Ling W, Mijiti A, Moming A. Survival pattern and prognostic factors of patients with squamous cell carcinoma of the tongue: a retrospective analysis of 210 cases[J]. J Oral Maxillofac Surg, 2013, 71(13): 775-85.
    [17]
    Yesuratnam A, Wiesenfeld D, Tsui A, et al. Preoperative evaluation of oral tongue squamous cell carcinoma with intraoral ultrasound and magnetic resonance imaging-comparison with histopathological tumour thickness and accuracy in guiding patient management[J]. Int J Oral Maxillofac Surg, 2014, 43(22): 787-94.
    [18]
    方言成, 李亚辉. 磁共振对老年人口腔颌面部肿瘤的诊断价值[J]. 中国老年学杂志, 2013, 10(9): 5151-2.
    [19]
    周 泉. 口腔颌面部恶性肿瘤术后短期复发的相关因素分析[J]. 中国社区医师, 2009, 18(3): 145-56.
    [20]
    National Comprehensive Cancer Network. NCCN clinical practice guidelines: head and neck cancers, version 12017[M]. Ft. Washington, PA: NCCN, 2017.
    [21]
    Goel R, Moore W, Sumer B, et al. Clinical Practice in PET/CT for the management of head and neck squamous cell cancer[J]. Am J Roentgenol, 2017, 209(4): 289-303.
    [22]
    Zhu L, Wang N. 18F-fluorodeoxyglucose positron emission tomography-computed tomography as a diagnostic tool in patients with cervical nodal metastases of unknown primary site: a meta-analysis[J]. Surg Oncol, 2013, 22(3): 190-4. doi: 10.1016/j.suronc.2013.06.002
    [23]
    胡小巧, 郭炳君, 陈晓品. PET/CT在恶性肿瘤治疗后评价中的作用与局限性[J]. 现代肿瘤学, 2015, 16(12): 2239-42.
    [24]
    Yamamoto Y, Wong TZ, Turkington TG, et al. Head and neck cancer: dedicated FDG PET/CT protocol for detection-phantom and initial clinical studies[J]. Radiology, 2007, 244(10): 263-72.
    [25]
    Li Z, Han C, Wang L, et al. Prognostic value of texture analysis based on pretreatment DWI-weighted MRI for esophageal squamous cell carcinoma patients treated with concurrent chemo-radiotherapy[J]. Front Oncol, 2019, 17(16): 1057-68.
    [26]
    Tezcan Ş, Uslu N, Öztürk FU, et al. Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with pathologic prognostic factors[J]. Eur J Breast Health, 2019, 15(3): 262-7.
    [27]
    Hayashi K, Kikuchi M, Imai Y, et al. Clinical value of fused PET/MRI for surgical planning in patients with oral/oropharyngeal carcinoma[J]. Laryngoscope, 2019, 49(121): 27911-23.
    [28]
    Catalano OA, Nicolai E, Rosen BR, et al. Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients[J]. Br J Cancer, 2015, 112(9): 1452-60. doi: 10.1038/bjc.2015.112
    [29]
    Cavaliere C, Romeo V, Aiello M, et al. Multiparametric evaluation by simultaneous PET-MRI examination in patients with histologically proven laryngeal cancer[J]. Eur J Radiol, 2017, 88(2): 47-55.
    [30]
    Huellner MW, Appenzeller P, Kuhn FP, et al. Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observations[J]. Radiology, 2014, 273(9): 859-69.
    [31]
    Rodrigues RS, Bozza FA, Christian PE, et al. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck[J]. J Nucl Med, 2009, 50(8): 1205-13. doi: 10.2967/jnumed.109.062075
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1156) PDF downloads(100) Cited by()
    Proportional views
    Related
    • Copyright © 2013《Journal of Molecular Imaging》 Editorial Office ICP备00000000号
    • Key tip: Adobe Reader6 The full text may be displayed abnormally，Please upgrade to Adobe Reader7Or higher .
    • Address: 1838 North Guangzhou Dadao, Guangzhou City, Guangdong Province, China Tel: 020-61648176 E-mail: 

    Supported by: Beijing Renhe Information Technology Co. Ltd  support: info@rhhz.net

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return